Trial Profile
A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 19 Jun 2017 Status changed from active, no longer recruiting to completed.
- 12 May 2017 Planned End Date changed from 1 Aug 2016 to 1 May 2017.
- 12 May 2017 Status changed from recruiting to active, no longer recruiting.